Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial

被引：0

作者：

Huang, Yu ^{[1
]}

Lu, Hong ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, NHC Key Lab Digest Dis, Shanghai Inst Digest Dis,Sch Med,Renji Hosp, Shanghai, Peoples R China

来源：

JOURNAL OF GASTROENTEROLOGY | 2024年 / 59卷 / 04期

关键词：

ERADICATION;

D O I：

10.1007/s00535-024-02085-z

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：358 / 358

页数：1

共 50 条

[41] Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
Suo Baojun
Tian Xueli
Zhang Hua
Lu Haoping
Li Cailing
Zhang Yuxin
Ren Xinlu
Yao Xingyu
Zhou Liya
Song Zhiqiang
中华医学杂志英文版, 2023, 136 (08)
[42] Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
Suo, Baojun
Tian, Xueli
Zhang, Hua
Lu, Haoping
Li, Cailing
Zhang, Yuxin
Ren, Xinlu
Yao, Xingyu
Zhou, Liya
Song, Zhiqiang
CHINESE MEDICAL JOURNAL, 2023, 136 (08) : 933 - 940
[43] Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
Yang, Jing
Zhang, Yi
Fan, Ling
Zhu, Yang-Jie
Wang, Ting-Yi
Wang, Xing-Wei
Chen, Dong-Feng
Lan, Chun-Hui
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03): : 437 - 445
[44] Bismuth quadruple regimen containing furazolidone and tetracycline as a promising strategy for Helicobacter pylori initial and rescue therapy: A prospective cohort study
Peng, Jianxiang
Xie, Jinliang
Wu, Shuang
Liu, Dingwei
Yang, Kaijie
Huang, Deqiang
Xie, Yong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 17 - 17
[45] Bismuth quadruple regimen containing furazolidone and tetracycline as a promising strategy for Helicobacter pylori initial and rescue therapy: A prospective cohort study
Peng, Jianxiang
Xie, Jinliang
Wu, Shuang
Liu, Dingwei
Yang, Kaijie
Huang, Deqiang
Xie, Yong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 17 - 17
[46] Inefficacy of Triple Therapy and Comparison of Two Different Bismuth-containing Quadruple Regimens as a Firstline Treatment Option for Helicobacter pylori
Kekilli, Murat
Onal, Ibrahim K.
Ocal, Serkan
Dogan, Zeynal
Tanoglu, Alpaslan
SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (05): : 366 - 369
[47] 10-day Sequential Versus 10-day Bismuth-Containing Quadruple Therapy As Empirical First-Line Treatment for Helicobacter pylori: An Open Label Randomized Crossover Trial
Liu, Sze Hang Kevin
Seto, Wai-Kay
Hung, Ivan F.
Leung, Wai K.
GASTROENTEROLOGY, 2013, 144 (05) : S54 - S54
[48] BISMUTH-CONTAINING QUADRUPLE THERAPY IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A FIRST REAL LIFE ITALIAN EXPERIENCE
Tursi, A.
Franceschi, M.
De Bastiani, R.
Elisei, W.
Baldassarre, G.
Ferronato, A.
Grillo, S.
Landi, S.
Zamparella, M.
Boscariolo, L.
Picchio, M.
Di Mario, F.
DIGESTIVE AND LIVER DISEASE, 2017, 49 : E142 - E142
[49] Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
Huh, Ki Young
Chung, Hyewon
Kim, Yu Kyong
Lee, SeungHwan
Bhatia, Siddharth
Takanami, Yohei
Nakaya, Ryou
Yu, Kyung-Sang
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 138 - 144
[50] The Effects of Multistrain Probiotic Compound on Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A Randomized Placebo-Controlled Triple-Blind Study
Shavakhi, Ahmad
Tabesh, Elham
Yaghoutkar, Arezoo
Hashemi, Houriye
Tabesh, Faezeh
Khodadoostan, Mahsa
Minakari, Mohammad
Shavakhi, Sara
Gholamrezaei, Ali
HELICOBACTER, 2013, 18 (04) : 280 - 284

← 1 2 3 4 5 →